ATRS Antares Pharma Inc.

3.14
+0.12  (+4%)
Previous Close 3.02
Open 3.08
Price To Book 12.08
Market Cap 510,626,207
Shares 162,619,811
Volume 4,893,657
Short Ratio
Av. Daily Volume 893,047

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved December 8, 2011.
Anturol
Overactive bladder
Approved Oct 14, 2013.
OTREXUP
Rheumatoid arthritis (RA)
Approval announced February 14, 2018.
Makena - auto injector
Reduce the risk of preterm birth in women with a singleton pregnancy
FDA Approval announced October 1, 2018.
XYOSTED (testosterone enanthate)
Testosterone deficiency

Latest News

  1. Antares Pharma to Present at the Raymond James 2019 Life Sciences and MedTech Conference
  2. Have Insiders Been Selling Antares Pharma, Inc. (NASDAQ:ATRS) Shares This Year?
  3. Antares Pharma to Present at the Jefferies 2019 Healthcare Conference
  4. Antares Pharma to Present at the B. Riley FBR Institutional Investor Conference
  5. Edited Transcript of ATRS earnings conference call or presentation 2-May-19 12:30pm GMT
  6. Investors Who Bought Antares Pharma (NASDAQ:ATRS) Shares Three Years Ago Are Now Up 265%
  7. Antares Pharma Inc (ATRS) Q1 2019 Earnings Call Transcript
  8. Antares Pharma: 1Q Earnings Snapshot
  9. Antares Pharma Reports First Quarter 2019 Operating and Financial Results
  10. Antares Pharma to Report First Quarter 2019 Financial and Operating Results
  11. Why Antares Pharma, Inc.'s (NASDAQ:ATRS) CEO Pay Matters To You
  12. New Research: Key Drivers of Growth for Progress Software, Antares Pharma, National Vision, NMI, Waters, and Kelly Services — Factors of Influence, Major Initiatives and Sustained Production
  13. Antares Pharma Announces Receipt of Orphan Drug Designation for the Treatment of Ectopic Pregnancy With Methotrexate
  14. Edited Transcript of ATRS earnings conference call or presentation 28-Feb-19 1:30pm GMT
  15. Antares Pharma Inc (ATRS) Files 10-K for the Fiscal Year Ended on December 31, 2018
  16. AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study
  17. Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference
  18. Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella
  19. Antares Pharma Inc (ATRS) Q4 2018 Earnings Conference Call Transcript
  20. Antares Pharma Reports Fourth Quarter and Full Year 2018 Operating and Financial Results